Showing results (41-50 of 132) with videos related to
Sort By:
Pageof 14
Annals of the New York Academy of Sciences|September 26, 2007
Intima-media thickness: a marker of accelerated atherosclerosis in women with systemic lupus erythematosusBarbara Maria Colombo, Giuseppe Murdaca, Matteo Caiti, et al.Vaccine|February 10, 2009
Flu vaccination with a virosomal vaccine does not affect clinical course and immunological parameters in scleroderma patientsMaurizio Setti, Daniela Fenoglio, Filippo Ansaldi, et al.Blood|October 24, 2002
Soluble HLA class I induces NK cell apoptosis upon the engagement of killer-activating HLA class I receptors through FasL-Fas interactionGrazia Maria Spaggiari, Paola Contini, Alessandra Dondero, et al.The Journal of Rheumatology|November 7, 2006
Migraine during systemic lupus erythematosus: findings from brain single photon emission computed tomographyFlavio Nobili, Alessandro Mignone, Edoardo Rossi, et al.Frontiers in Immunology|June 10, 2021
CMTM6-Deficient Monocytes in ANCA-Associated Vasculitis Fail to Present the Immune Checkpoint PD-L1Markus Zeisbrich, Nina Chevalier, Bettina Sehnert, et al.Rheumatology (Oxford, England)|January 16, 2023
Mitochondrial DNA: a novel indicator of active inflammation in ANCA-associated vasculitidesStavros Giaglis, Douglas Daoudlarian, Jens Thiel, et al.Vaccine|July 12, 2005
In utero DNA immunisation. Immunity over tolerance in fetal lifeMarta Rizzi, Mara Gerloni, Anand S Srivastava, et al.The American Journal of Gastroenterology|April 22, 2008
Small intestinal bacterial overgrowth in patients suffering from scleroderma: clinical effectiveness of its eradicationAndrea Parodi, Marta Sessarego, Alfredo Greco, et al.Journal of Clinical Microbiology|October 7, 2005
Decay of human immunodeficiency virus type 1 unintegrated DNA containing two long terminal repeats in infected individuals after 3 to 8 years of sustained control of viremiaJennifer L McDermott, Isabella Martini, Davide Ferrari, et al.Blood|November 25, 2003
Migration of V delta 1 and V delta 2 T cells in response to CXCR3 and CXCR4 ligands in healthy donors and HIV-1-infected patients: competition by HIV-1 TatAlessandro Poggi, Roberta Carosio, Daniela Fenoglio, et al.Pageof 14